-
Symbol
-
KROS on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Shares Owned
-
0 shares
-
Security Ownership %
-
0%
Pontifax Management 4 GP (2015) Ltd. ownership in Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS)
16 Oct 2025 - Pontifax Management 4 GP (2015) Ltd. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS).
This represents 0% ownership of the company.
In their previous filing dated 18 Apr 2025, Pontifax Management 4 G.P. (2015) Ltd. had reported owning 4,787,331 shares, indicating a decrease of +100%.
.